Part D/Prescription Drugs – Page 25 – medicarereport.org

Monday, December 15, 2025

Latest:

Health Care - General Part D/Prescription Drugs

Arlene Sharp May 23, 2024May 23, 2024 #biotech #obesity #amacfoundation

Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy

By Allison DeAngelis and Elaine Chen May 23, 2024 for Stat News Enticed by the immense market opened by GLP-1 weight loss

Health Care - General Part D/Prescription Drugs

Arlene Sharp May 21, 2024May 21, 2024 Healthcare Costs, Medicare Part D

High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Treatment

By Renuka Rayasam on May 21, 2024 for KFF Health News The makers of Ozempic and Mounjaro charge list prices

Health Care - General Medicare Advantage Part D/Prescription Drugs

Arlene Sharp May 20, 2024May 20, 2024 Medicare Advantage, Medicare Part D, Older Adults

Medicare Advantage Plans Are About to Change

By Suzanne Blake on May 18, 2024 for Newsweek Medicare Advantage patients may be in for a rude awakening as

CMS Health Care - General Health Insurance Medicare - General Part D/Prescription Drugs

Arlene Sharp May 20, 2024May 20, 2024

Anuzis: Biden plans costing seniors more

By Paul Anuzis on May 18, 2024 for Daily Independent When President Joe Biden took office, he embarked on a

Medicare - General Part D/Prescription Drugs

Eileen Cook May 15, 2024May 15, 2024 medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Seniors

New KFF Poll Finds that Many Older Voters Are Unaware of Medicare Drug Price Negotiation, But Awareness Has Grown

(By Chris Lee and Craig Palosky for The Kaiser Family Foundation published May 15, 2024) A new KFF poll finds

FDA Part D/Prescription Drugs PTSD

Eileen Cook May 14, 2024May 14, 2024 Ecstasy, FDA, PTSD

As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence

(By Will Stone for NPR) In a matter of months, the Food and Drug Administration is expected to decide whether

CMS Emerging Health Issues Health Care - General Health Insurance Medicare - General Part D/Prescription Drugs

Eileen Cook May 10, 2024May 10, 2024 CMS, Diabetes, Emerging Healthcare, GLP-1s drugs, Healthcare Costs, heart disease, medicare, Medicare Part D, Mounjaro, Obesity, Ozempic, Wegovy

Poll: 1 in 8 Adults Say They’ve Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease

(By Tammie Smith at The Kaiser Family Foundation published May 10, 2024) About one in eight adults (12%) say they

CMS Health Care Finance Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook May 7, 2024May 7, 2024 CMS, Hospital Insurance Trust Fund, medicare, Medicare Advantage, Medicare Part D

Medicare’s financial picture brightens slightly

(By Rylee Wilson for Becker’s Hospital Review) Medicare’s hospital insurance trust fund is expected to run out in 2036, five years

Health Care Finance Part D/Prescription Drugs

Eileen Cook May 7, 2024May 7, 2024 Health Technology Assessments, Healthcare Costs, Healthcare Finance, Medicare Part D, Value-based drug pricing

The world is relying on the United States to get value-based drug pricing right

(By Jason Shafrin, Louis Garrison, and Melanie D. Whittington for STAT) The changing landscape of drug pricing policy in the

Aging Alzheimer's/Dementia Health Care Finance Health Insurance Medicare - General Medicare Advantage Nursing Homes Part D/Prescription Drugs Women's Health

Eileen Cook May 2, 2024May 2, 2024 Alzheimer's Disease, CMS, Dementia, Healthcare Costs, Healthcare Finance, medicare, Medicare Advantage, Medicare Part D, Older Adults, Women's Health

10 Key Facts About Women with Medicare

(By Meredith Freed, Juliette Cubanski, Michelle Long, Nancy Ochieng, Tricia Neuman, and Alina Salganicoff for The Kaiser Family Foundation Published: